Lipocine ($LPCN) Insider Trading & Smart Money Activity
Lipocine Inc. ($LPCN) has 5 insider trades on file. In the last 12 months on the open market, 1 insider bought ($82.17K) and no insider sold, net +$82.17K.
- Insider buyers (12 mo)
- 1
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$82.17K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
LPCN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 3 · $82.17K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All LPCN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Higuchi John W.Director | Buy (Open-market buy) | 15.97K sh | $35.61K | 0.0% | — | |||||
| Insider | Higuchi John W.Director | Buy (Open-market buy) | 9.04K sh | $19.43K | -2.8% | — | |||||
| Insider | Higuchi John W.Director | Buy (Open-market buy) | 12.56K sh | $27.13K | -1.0% | — | |||||
| Insider | Mahesh PatelChief Executive Officer | Buy (Grant or award) | 52.78K sh | $131.42K | -0.8% | -16.9% | — | ||||
| Insider | Mahesh PatelChief Executive Officer | Buy (Grant or award) | 52.78K sh | $131.42K | -0.8% | -16.9% | Read |
1W / 1M / 6M = how LPCN moved from the trade or filing date.
Insider trading in LPCN: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Higuchi John W. | Director | 3 | +$82.17K | Sep 30, 2026 | |
| Mahesh Patel | Chief Executive Officer | 2 | — | Jun 29, 2026 |
Frequently asked questions
Are LPCN insiders buying or selling?
Over the last 12 months 1 insider made 3 open-market purchases worth $82.17K and 0 insiders made 0 open-market sales worth $0, a net +$82.17K.
What is the latest insider trade in LPCN?
Higuchi John W., Director filed a buy (open-market buy) of 15.97K sh worth $35.61K on Sep 30, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.